Analytical Data
-
Gene name
Rh2b
- Application
-
Alternative Names
(PfR2Hb)(PfRH2b)
-
Species
Plasmodium falciparum
-
Source
E. coli
-
Tag
Tag Free
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
C0H5F4
-
Expression Region
1800-2000aa
-
Molecular Weight
23.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on Rh2b recombinant protein is rooted in its significance in the field of immunology and biotechnology, particularly due to its potential applications in vaccine development and cancer therapy. Rh2b, a member of the Rh family of proteins, plays a crucial role in various physiological processes, including ion transport and cellular signaling. Because of its involvement in these critical functions, scientists are interested in characterizing Rh2b for its therapeutic possibilities. The recombinant expression of the Rh2b protein allows for the production of large quantities of the protein necessary for detailed study, enabling researchers to understand its structure and function at a molecular level. This understanding paves the way for developing targeted therapies that can modulate immune responses or enhance the efficacy of existing treatments. Furthermore, the potential of Rh2b as a biomarker for certain diseases adds another layer of interest, motivating ongoing investigations into its diagnostic and therapeutic implications. Ultimately, the research aims to leverage the unique properties of Rh2b to advance our knowledge in medical science and contribute to innovative treatments for a variety of health conditions.
